Description
Caffeine Citrate Oral / Injectable Solution
Healthy Inc is a specialized global supplier and exporter of advanced neonatology, critical care, and pediatric therapeutics. We provide ultra-high-purity, kinetically stabilized Caffeine Citrate Solution, manufactured in WHO–GMP certified, high-precision sterile facilities. This “Methylxanthine Respiratory Stimulant” is a critical strategic export to NICUs (Neonatal Intensive Care Units), specialized pediatric hospitals, and government health ministries, serving as the globally mandated intervention for the short-term treatment of idiopathic apnea of prematurity in infants.
Product Overview
This formulation operates as a “Neurological Drive Stimulator.” It physically crosses the blood-brain barrier to target the respiratory control centers, ensuring the premature infant maintains a consistent, physical breathing rhythm.
Mechanism 1 (Adenosine Receptor Antagonism): Caffeine physically blocks Adenosine A1 and A2A receptors. Since adenosine normally inhibits neuronal activity, blocking it physically increases the firing rate of the respiratory neurons.
Mechanism 2 (Medullary Stimulant): It physically increases the sensitivity of the Medullary Respiratory Center to carbon dioxide ($CO_{2}$), forcing the body to breathe more consistently.
Mechanism 3 (Diaphragmatic Strength): It physically enhances the contractility of the diaphragm and increases metabolic rate, reducing the physical effort required for a neonate to ventilate the lungs.
Product Composition & Strength
We supply this product as a Sterile, Preservative-Free Aqueous Solution, optimized for both oral administration and intravenous infusion.
| Active Ingredient | Strength (per mL) | Primary Clinical Function |
| Caffeine Citrate USP/BP | 20 mg/mL | The Stimulant: Equivalent to 10mg of Caffeine base. |
| Excipients | Water for Injection / Citric Acid | The Sterile Matrix: pH-adjusted for neonatal safety. |
Technical & Logistics Specifications
HS Code: 3004.43.00 (Medicaments containing Alkaloids or their derivatives)
CAS Number: 69-22-7 (Caffeine Citrate)
Dosage Form: Sterile Solution (Oral/Injectable)
Packaging: 3ml / 5ml Clear Glass Vials or Ampoules. Our specialized sterile packaging ensures 24-month stability in controlled environments.
Manufacturing Authority & Compliance
Aseptic Filling Excellence: Our manufacturing process utilizes Class 100 (ISO 5) Aseptic Filling Lines. Given that this product is for premature neonates with underdeveloped immune systems, 100% sterility is our absolute physical priority.
Preservative-Free Guarantee: Our solution is 100% free from preservatives (like Benzyl Alcohol), which are physically toxic to newborns, meeting the strictest international NICU safety standards.
Precision pH Buffering: We utilize Advanced Citrate Buffering to ensure the solution is physically stable and non-irritating to the neonatal gastric mucosa or venous lining.
Primary Indications
Neonatology: Treatment of Apnea of Prematurity in infants between 28 and 32 weeks of gestational age.
Critical Care: Facilitating the Extubation (removal from a ventilator) of premature infants by maintaining respiratory drive.
Dosage & Administration
Loading Dose: Typically 20 mg/kg (1 mL/kg) administered via slow IV infusion or orally.
Maintenance Dose: Typically 5 mg/kg (0.25 mL/kg) administered once every 24 hours.
Administration: Can be given physically via an orogastric tube or as a slow IV infusion. Monitoring of serum caffeine levels is physically recommended for long-term use.
Safety Warning: Preservative-Free. Cardiac Warning: Monitor for tachycardia (high heart rate) and cardiac arrhythmias. Metabolic Note: May cause increased urine output or jitteriness. Contraindication: Do not use if known hypersensitivity to xanthine derivatives exists.
Global Export & Contract Manufacturing
Healthy Inc is a premier Neonatology and Critical Care Pharmaceutical Exporter in India. As a verified Medicine Supplier in Mumbai, we offer flexible Third Party Manufacturing (Contract Manufacturing) for high-precision sterile liquids. Whether you are a Specialized Children’s Hospital in the Middle East or a B2B Pharma Marketplace partner in Europe, the CIS, or SE Asia, we ensure secure, WHO-GMP compliant delivery.









Reviews
There are no reviews yet.